{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:50:54Z","timestamp":1785837054363,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","prosdent.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prosthetic Dentistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.prosdent.2019.12.025","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T01:19:52Z","timestamp":1583803192000},"page":"257-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis"],"prefix":"10.1016","volume":"125","author":[{"given":"Jiaying","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prosdent.2019.12.025_bib1","first-page":"141325","article-title":"Oral candidiasis: An overview","volume":"18","author":"Singh","year":"2014","journal-title":"J\u00a0Oral Maxillofac Pathol"},{"key":"10.1016\/j.prosdent.2019.12.025_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/pmj.78.922.455","article-title":"Oral candidiasis","volume":"78","author":"Akpan","year":"2002","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.prosdent.2019.12.025_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.archoralbio.2014.04.010","article-title":"Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity","volume":"59","author":"Alves","year":"2014","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.prosdent.2019.12.025_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0149-2918(98)80033-7","article-title":"Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies","volume":"20","author":"Epstein","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.prosdent.2019.12.025_bib5","first-page":"1","article-title":"Clinical and microbiological diagnosis of oral candidiasis","volume":"5","author":"Coronado-Castellote","year":"2013","journal-title":"J\u00a0Clin Exp Dent"},{"key":"10.1016\/j.prosdent.2019.12.025_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0924-8579(95)00050-X","article-title":"Oral candidiasis: the clinical challenge of resistance and management","volume":"6","author":"Hoepelman","year":"1996","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.prosdent.2019.12.025_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10266-009-0118-3","article-title":"Antifungal drug resistance of oral fungi","volume":"98","author":"Niimi","year":"2010","journal-title":"Odontology"},{"key":"10.1016\/j.prosdent.2019.12.025_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.ebd.6401032","article-title":"Antifungal medications or disinfectants for denture stomatitis","volume":"15","author":"Lalla","year":"2014","journal-title":"Evid Based Dent"},{"key":"10.1016\/j.prosdent.2019.12.025_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tripleo.2003.12.028","article-title":"A\u00a0double-dummy, double-blind, placebo-controlled phase III study comparing the efficacy and efficiency of miconazole chewing gum with a known drug (Brentan gel) and a placebo in patients with oral candidosis","volume":"98","author":"Bastian","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.prosdent.2019.12.025_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/cncr.23152","volume":"112","author":"Bensadoun","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.prosdent.2019.12.025_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00006454-199703000-00007","article-title":"Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group","volume":"16","author":"Hoppe","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.prosdent.2019.12.025_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF01713319","article-title":"Randomized comparison of two nystatin oral gels with miconazole oral gel for treatment of oral thrush in infants. Antimycotics Study Group","volume":"24","author":"Hoppe","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.prosdent.2019.12.025_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00126334-200402010-00007","article-title":"Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis","volume":"35","author":"Van Roey","year":"2004","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.prosdent.2019.12.025_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1310\/hct1104-186","article-title":"Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole Lauriad(R) efficacy and safety (SMiLES)","volume":"11","author":"Vazquez","year":"2010","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.prosdent.2019.12.025_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3913(89)80045-9","article-title":"Clinical evaluation of a nystatin pastille for treatment of denture-related oral candidiasis","volume":"61","author":"Johnson","year":"1989","journal-title":"J\u00a0Prosthet Dent"},{"key":"10.1016\/j.prosdent.2019.12.025_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0030-4220(75)90348-5","article-title":"Nystatin and amphotericin B in the treatment of denture-related candidiasis","volume":"40","author":"Nairn","year":"1975","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.prosdent.2019.12.025_bib17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00006454-200212000-00017","article-title":"Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants","volume":"21","author":"Goins","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.prosdent.2019.12.025_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/00016359850142790","article-title":"Fluconazole versus nystatin in the treatment of oral candidosis","volume":"56","author":"Blomgren","year":"1998","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.prosdent.2019.12.025_bib19","first-page":"159","article-title":"Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis","volume":"26","author":"De Wit","year":"1998","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.prosdent.2019.12.025_bib20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(89)92572-5","article-title":"Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS","volume":"1","author":"De Wit","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.prosdent.2019.12.025_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)00307-0","article-title":"Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV\/AIDS patients","volume":"104","author":"Graybill","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.prosdent.2019.12.025_bib22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF01974616","article-title":"Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group","volume":"13","author":"Hernandez-Sampelayo","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.prosdent.2019.12.025_bib23","first-page":"55","article-title":"Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study","volume":"21","author":"Leen","year":"1990","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.prosdent.2019.12.025_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-4362.2000.00087.x","article-title":"Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients","volume":"39","author":"Linpiyawan","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.prosdent.2019.12.025_bib25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00042560-199608150-00005","article-title":"Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis","volume":"12","author":"MacPhail","year":"1996","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.prosdent.2019.12.025_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5694\/j.1326-5377.1993.tb121784.x","article-title":"Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study","volume":"158","author":"Marriott","year":"1993","journal-title":"Med J Aust"},{"key":"10.1016\/j.prosdent.2019.12.025_bib27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/514744","article-title":"Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"McKinsey","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.prosdent.2019.12.025_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0149-2918(97)80131-2","article-title":"Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients","volume":"19","author":"Murray","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.prosdent.2019.12.025_bib29","first-page":"45","article-title":"Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients","volume":"72","author":"Nyst","year":"1992","journal-title":"Ann Soc Belg Med Trop"},{"key":"10.1016\/j.prosdent.2019.12.025_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jac\/dkf101","article-title":"Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial","volume":"50","author":"Pagani","year":"2002","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.prosdent.2019.12.025_bib31","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516342","article-title":"A\u00a0double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS","volume":"26","author":"Phillips","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.prosdent.2019.12.025_bib32","first-page":"1311","article-title":"Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group","volume":"6","author":"Pons","year":"1993","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.prosdent.2019.12.025_bib33","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1086\/513664","article-title":"Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions","volume":"24","author":"Pons","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.prosdent.2019.12.025_bib34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-126-9-199705010-00003","article-title":"Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"126","author":"Schuman","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.prosdent.2019.12.025_bib35","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/archinte.1991.00400120096018","article-title":"Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily","volume":"151","author":"Stevens","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.prosdent.2019.12.025_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3476(95)70321-7","article-title":"Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group","volume":"127","author":"Flynn","year":"1995","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.prosdent.2019.12.025_bib37","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.ejca.2004.03.003","article-title":"An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis","volume":"40","author":"Oude Lashof","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prosdent.2019.12.025_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000239469","article-title":"Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group","volume":"42","author":"de Repentigny","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1016\/j.prosdent.2019.12.025_bib39","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.34.11.2267","article-title":"Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus","volume":"34","author":"Koletar","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.prosdent.2019.12.025_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.prosdent.2019.12.025_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.prosdent.2019.12.025_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of Candida species infections in critically ill non-immunosuppressed patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.prosdent.2019.12.025_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.01391","article-title":"Clinical appearance of oral Candida infection and Therapeutic Strategies","volume":"6","author":"Patil","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.prosdent.2019.12.025_bib44","first-page":"0975","article-title":"Candida in potentially malignant oral disorders","volume":"7","author":"Sankari","year":"2015","journal-title":"J\u00a0Pharm Bioallied Sci"},{"key":"10.1016\/j.prosdent.2019.12.025_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1439-0507.1997.tb00230.x","article-title":"Fluconazole: comparison of pharmacokinetics, therapy and in\u00a0vitro susceptibility","volume":"40","author":"Wildfeuer","year":"1997","journal-title":"Mycoses"},{"key":"10.1016\/j.prosdent.2019.12.025_bib46","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.prosdent.2019.12.025_bib47","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","volume":"2","author":"Gotzsche","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prosdent.2019.12.025_bib48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.prosdent.2019.12.025_bib49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.prosdent.2019.12.025_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00134-008-1338-7","article-title":"Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis","volume":"35","author":"Guery","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.prosdent.2019.12.025_bib51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00134-008-1339-6","article-title":"Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment","volume":"35","author":"Guery","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.prosdent.2019.12.025_bib52","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.bmcl.2007.04.038","article-title":"Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety","volume":"17","author":"Lebouvier","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.prosdent.2019.12.025_bib53","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2165\/00003495-199549060-00009","article-title":"Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis","volume":"49","author":"Perry","year":"1995","journal-title":"Drugs"}],"container-title":["The Journal of Prosthetic Dentistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022391320300767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022391320300767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T10:54:37Z","timestamp":1758365677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022391320300767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0022391320300767"],"URL":"https:\/\/doi.org\/10.1016\/j.prosdent.2019.12.025","relation":{},"ISSN":["0022-3913"],"issn-type":[{"value":"0022-3913","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prosthetic Dentistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prosdent.2019.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the Editorial Council for The Journal of Prosthetic Dentistry.","name":"copyright","label":"Copyright"}]}}